SA
Sign upLog In

Ligand Pharmaceuticals Inc (LGND)

Accounts Payable

$9.41M

Quarterly · Period ending: · USD

LGND logo

LGND Accounts Payable

Latest reported$9.41M
LGND Quarterly Accounts Payable ($1.00M → $9.41M)
High-resolution chart · PNG

LGND accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
9,405,000
5,264,000
3,238,000
27,763,000
8,584,000
5,366,000
5,233,000
4,694,000
1,793,000
1,893,000
2,427,000
2,475,000
9,582,000
6,135,000
5,307,000
15,887,000
19,153,000
6,972,000
8,403,000
7,233,000
17,273,000
9,469,000
3,784,000
10,169,000
6,103,000
3,365,000
2,420,000
2,040,000
2,888,000
5,061,000
4,183,000
1,647,000
2,682,000
3,407,000
2,259,000
3,617,000
1,799,000
6,456,000
2,734,000
2,757,000
2,336,000
2,688,000
4,083,000
3,143,000
2,708,000
7,442,000
7,698,000
4,864,000
5,059,000
3,675,000
3,951,000
4,304,000
4,755,000
5,522,000
5,854,000
6,027,000
6,746,000
7,893,000
11,065,000
10,072,000
10,628,000
13,032,000
8,597,000
11,339,000
13,445,000
14,519,000
16,945,000
14,379,000
14,844,000
15,641,000
14,627,000
9,014,000
10,290,000
10,760,000
12,682,000
10,448,000
10,939,000
13,181,000
12,259,000
16,080,000
19,460,000
16,325,000
15,360,000
9,809,000
14,276,000
14,586,000
17,352,000
16,719,000
20,225,000
16,866,000
18,841,000
17,261,000
10,819,000
13,441,000
11,979,000
9,662,000
10,026,000
7,033,000
5,385,000
4,418,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.